Loading chat...
HI HR174
Resolution
Status
Passed
4/4/2024
Primary Sponsor
Trish La Chica
Click for details
AI Summary
- Department of Law Enforcement requested to conduct a study on whether xylazine testing strips should be excluded from Hawaii's drug paraphernalia definition
- Study must address xylazine's role as a cutting agent in illicit drugs (often mixed with fentanyl), its presence in 48 of 50 states, and its association with one in ten fatal fentanyl overdoses
- Study should consider that naloxone does not counteract xylazine effects and no FDA-approved reversal agent exists for xylazine in humans
- Department must submit findings, recommendations, and any proposed legislation to the Legislature no later than 20 days before the 2025 Regular Session convenes
- Certified copy of resolution to be transmitted to the Director of Law Enforcement
Legislative Description
Requesting The Department Of Law Enforcement To Conduct A Study To Determine If Xylazine Testing Strips Should Be Excluded From The State's Definition Of Drug Paraphernalia.
Study
Last Action
Resolution adopted in final form.
4/4/2024
Committee Referrals
Judiciary & Hawaiian Affairs3/14/2024
Full Bill Text
No bill text available